Drug profile · INN
estramustine phosphate sodium
EMCYT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
estramustine phosphate sodium (EMCYT) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN estramustine phosphate sodium
Brand EMCYT
Route ORAL
Formulation CAPSULE
Frequently asked questions
What is estramustine phosphate sodium?
estramustine phosphate sodium (EMCYT) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for estramustine phosphate sodium?
EMCYT is a marketed brand name for estramustine phosphate sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of estramustine phosphate sodium?
estramustine phosphate sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.